New Zealand Pharmaceuticals

Heparin

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  Bemiparin;Certoparin;Cy 222;Fluxum;Parnaparin;Reviparin;Sandoparin;Ardeparin;Arteven;CY 216;Clexane;Clivarin;Clivarine;Dalteparin;Eparina;Eparina [DCIT];FR 860;Fragmin A;Fragmin B;Fraxiparin;HSDB 3094;Hed-heparin;Heparin CY 216;Heparin sulfate;Heparina;Heparina [INN-Spanish];Heparinate;Heparine;Heparine [INN-French];Heparinic acid;Heparinum;Heparinum [INN-Latin];Hepathrom;KB 101;LMWH;Lipo-hepin;Liquaemin;Liquemin;Multiparin;Nadroparin;Nadroparine;Novoheparin;OP 386;OP 622;Octaparin;Pabyrin;Parvoparin;Pularin;Subeparin;Sublingula;Thromboliquine;Tinzaparin;Triofiban;UNII-E47C0NF7LV;UNII-T2410KM04A;Vetren;Vitrum AB;alpha-Heparin;depo-Heparin;N-(2-bromobenzyl)-N,N-dimethylethanaminium;2-(carbamoyloxy)-N,N,N-trimethylethanaminium;1,1-diphenyl-4-(piperidin-1-yl)butan-1-ol;N-ethyl-3-hydroxy-N,N-dimethylanilinium;2-{2-[(5-carboxypentyl)amino]-2-oxo-1-[(phenylacetyl)amino]ethyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid;(6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;(2S,3S,4R,5R,6R)-3-({(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-[(sulfooxy)methyl]tetrahydro-2H-pyran-2-yl}oxy)-6-{[(2S,3S,4S,5R,6S)-6-{[(2R,3S,4S,5R)-2-carboxy-4,6-dihydroxy-5-(sulfooxy)tetrahydro-2H-pyran-3-yl]oxy}-2-hydroxy-4-(sulfomethyl)-5-(sulfooxy)tetrahydro-2H-pyran-3-yl]oxy}-4,5-dihydroxytetrahydro-2H-pyran-2-carboxylic acid (non-preferred name);

• CAS NO :

  9005-49-6

• EC NO :

  232-681-7

• Molecular Formula :

  C₂₆H₄₁NO₃₄S₄

• Molecular Weight :

  1039.85

• Main Specifications :

• InChI :

  InChI=1/C26H41NO34S4/c1-4(28)27-7-9(30)8(29)6(2-52-63(43,44)45)53-24(7)56-15-10(31)11(32)25(58-19(15)21(36)37)55-13-5(3-62(40,41)42)14(60-64(46,47)48)26(59-22(13)38)57-16-12(33)17(61-65(49,50)51)23(39)54-18(16)20(34)35/h5-19,22-26,29-33,38-39H,2-3H2,1H3,(H,27,28)(H,34,35)(H,36,37)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)/t5-,6+,7+,8+,9+,10+,11+,12-,13-,14+,15-,16-,17+,18+,19-,22-,23?,24+,25+,26-/m0/s1

• Product description :

  ；Heparin is needed to anticoagulant effect, and can be used for the first drug prevention thrombosis and surgical treatment of pregnancies for anticoagulation patients with acute myocardial infarction, can prevent the intravenous heparin, and bolt embolization can prevent large front wall through wall of myocardial infarction patients occurring artery embolization, etc.；

• Molecular Structure :